From the Departments of Psychiatry (O.F., C.F.-R.), Radiology (M.L.), and Pathology (J.M.), and the Infectious Disease Unit (N.B.), Massachusetts General Hospital; and the Departments of Psychiatry (O.F., C.F.-R.), Medicine (N.B.), Radiology (M.L.), and Pathology (J.M.), Harvard Medical School — both in Boston.
Founded by Richard C. Cabot
Nancy Lee Harris, M.D., Editor
Jo-Anne O. Shepard, M.D., Associate Editor
Eric S. Rosenberg, M.D., Associate Editor
Alice M. Cort, M.D., Associate Editor
Sally H. Ebeling, Assistant Editor
Christine C. Peters, Assistant Editor
Dr. Freudenreich reports receiving consulting fees from Beacon Health Strategies and Transcept Pharmaceuticals, grant money from Pfizer, and honoraria from Reed Medical Education. Dr. Basgoz reports receiving stock options and income for board membership from Forest Laboratories. No other potential conflict of interest relevant to this article was reported.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
Presented at the Psychiatry Grand Rounds.
